HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer Read more
WeRide Named to Fortune Future 50 List, Recognizing Global Leadership in Autonomous Driving Tech Read more
Diesel Generator Market worth $23.4 Billion by 2029, Globally, at a CAGR of 5.4%, says MarketsandMarkets™ Read more